Ticker > Company >

Syngene Internation. share price

Syngene International Ltd.

NSE: SYNGENE BSE: 539268 SECTOR: Business Support  1.88 L   549   108

650.45
+2.25 (0.35%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 657.9

Today's Low

₹ 642.6

52 Week High

₹ 960

52 Week Low

₹ 598.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

26209.19 Cr.

Enterprise Value

25659.19 Cr.

No. of Shares

40.29 Cr.

P/E

55.99

P/B

5.59

Face Value

₹ 10

Div. Yield

0.19 %

Book Value (TTM)

₹  116.28

CASH

652.5 Cr.

DEBT

102.5 Cr.

Promoter Holding

52.68 %

EPS (TTM)

₹  11.62

Sales Growth

5.31%

ROE

10.65 %

ROCE

14.39%

Profit Growth

0.32 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year5.31%
3 Year9.05%
5 Year10.89%

Profit Growth

1 Year0.32%
3 Year5.92%
5 Year2.61%

ROE%

1 Year10.65%
3 Year12.24%
5 Year13.3%

ROCE %

1 Year14.39%
3 Year14.59%
5 Year14.46%

Debt/Equity

0.0222

Price to Cash Flow

23.53

Interest Cover Ratio

20.9231

CFO/PAT (5 Yr. Avg.)

1.88018140589569

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 52.68 0.00
Mar 2025 52.74 0.00
Dec 2024 52.74 0.00
Sep 2024 54.72 0.00
Jun 2024 54.72 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 20.9231.
  • The Company has been maintaining an effective average operating margins of 28.3810846527858% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -6339.8108 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.88018140589569.
  • The company has a high promoter holding of 52.68%.

 Limitations

  • The company has shown a poor profit growth of 5.92294500922625% for the Past 3 years.
  • The company has shown a poor revenue growth of 9.04746329662722% for the Past 3 years.
  • The company is trading at a high PE of 55.99.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 726.5 821.3 877.1 948.4 799.3
Total Expenditure 578.3 616.7 627.4 638.4 631.2
Operating Profit 148.2 204.6 249.7 310 168.1
Other Income 17.7 20.4 19.1 18.4 16.6
Interest 7.4 7 6.7 10.1 5.9
Depreciation 91.7 93.7 92.3 89.6 94.6
Exceptional Items 32 0 0 0 0
Profit Before Tax 98.8 124.3 169.8 228.7 84.2
Tax 24.9 27.7 46.7 54.3 10.2
Profit After Tax 73.9 96.6 123.1 174.4 74
Adjusted EPS (Rs) 1.84 2.4 3.06 4.33 1.84

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 2179.4 2601.4 3193.5 3203.1 3373.3
Total Expenditure 1528.1 1863.6 2260.9 2324.4 2455.8
Operating Profit 651.3 737.8 932.6 878.7 917.5
Other Income 83.3 108.4 72.6 88 70.5
Interest 27.7 24.1 45.2 29.5 31.2
Depreciation 274.5 309.7 359.1 368.8 367.2
Exceptional Items 35 -30.7 0 -11.1 32
Profit Before Tax 467.4 481.7 600.9 557.3 621.6
Tax 63.7 87.9 127.9 90.8 153.6
Net Profit 403.7 393.8 473 466.5 468
Adjusted EPS (Rs.) 10.09 9.83 11.78 11.6 11.63

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 400 400.8 401.4 402 402.5
Total Reserves 2418.3 2891.2 3217.5 3789.5 4236.4
Borrowings 512.4 531.5 489 100 0
Other N/C liabilities 327.7 440.7 291.4 394 409.5
Current liabilities 1130.4 1231.5 1157.2 1098.6 1328.6
Total Liabilities 4788.8 5495.7 5768.4 5784.1 6377
Assets
Net Block 2163.4 2354.3 2211.8 2276.8 2206.9
Capital WIP 237.2 346.4 126.2 758.3 875.4
Intangible WIP 0 0 0 1.3 4.7
Investments 279 270.6 116.4 435 870.1
Loans & Advances 115.1 150.7 164.5 230.3 173.1
Other N/C Assets 193.1 170.1 794.2 230.6 212.9
Current Assets 1801 2203.6 2355.3 1851.8 2033.9
Total Assets 4788.8 5495.7 5768.4 5784.1 6377
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 467.4 481.7 600.9 557.3 621.6
Adjustment 278.6 381.3 375.3 286.3 366.1
Changes in Assets & Liabilities 34.8 -176.6 -4.1 168.2 227.6
Tax Paid -82.8 -104.2 -133.7 -98.4 -101.5
Operating Cash Flow 698 582.2 838.4 913.4 1113.8
Investing Cash Flow -628.9 -610.8 -685.1 -382.6 -810.4
Financing Cash Flow 58 -31.3 -340.2 -536.3 -136.5
Net Cash Flow 127.1 -59.9 -186.9 -5.5 166.9

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 54.72 54.72 52.74 52.74 52.68
biocon limited 54.45 54.45 52.46 52.46 52.41
biocon limited employee w... 0.26 0.26 0.26 0.26 0.26
kiran mazumdar shaw 0.01 0.01 0.01 0.01 0.01
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 45.28 45.28 47.26 47.26 47.32
dsp arbitrage fund - - - - 3.34
government of singapore 2.94 2.94 2.94 2.94 2.94
government pension fund g... 1.97 1.92 1.94 2.48 2.57
icici prudential mutual f... - - - - 5.38
independent directors - - - - 0.01
lici new endowment plus-g... 1.22 - - 1.78 1.78
mirae asset flexi cap fun... - - - - 3.92
nippon life india trustee... - - - - 2.96
uti-flexi cap fund - - - - 1.50
dsp nifty healthcare etf - - - 1.12 -
icici prudential innovati... - 5.20 - 5.13 -
mirae asset equity saving... - 1.87 - 3.94 -
nippon life india trustee... - - - 1.87 -
uti nifty midsmallcap 400... - - - 1.83 -
icici prudential mutual f... - - 4.41 - -
kotak funds - india midca... 1.13 1.04 1.01 - -
lici new pension plus gro... - - 1.78 - -
mirae asset nifty midcap ... - - 3.37 - -
nippon life india trustee... - - 1.94 - -
uti nifty midcap 150 qual... - 1.72 1.75 - -
lici ulip-growth fund - 1.73 - - -
nippon life india trustee... - 1.92 - - -
icici prudential large & ... 6.26 - - - -
mirae asset focused fund 1.41 - - - -
nippon life india trustee... 1.54 - - - -
uti-unit linked insurance... 1.83 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2025
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit ICRA
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit CRISIL
Credit ICRA
Credit CRISIL
Credit ICRA
Credit ICRA
Credit ICRA
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research ICICI Securities Limited

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q2FY24
Concall Q1FY21
Concall Q1FY20
Concall Q3FY20
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q4FY21
Presentation Q3FY25
Presentation Q3FY25
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY25
Presentation Q2FY25
Presentation Q2FY24
Presentation Q2FY22
Presentation Q2FY21
Presentation Q1FY22
Presentation Q1FY21
Presentation Q1FY20

Company News

Syngene Internation. Stock Price Analysis and Quick Research Report. Is Syngene Internation. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Syngene Internation.. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Syngene Internation. has a PE ratio of 55.9089617890868 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Syngene Internation. has ROA of 7.6967% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Syngene Internation. has a Current ratio of 1.5309.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Syngene Internation. has a ROE of 10.6543%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Syngene Internation. has a Debt to Equity ratio of 0.0222 which means that the company has low proportion of debt in its capital.

  • Sales growth: Syngene Internation. has reported revenue growth of 5.3136% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Syngene Internation. for the current financial year is 27.1988853644799%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Syngene Internation. is Rs 1.25 and the yield is 0.1924%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Syngene Internation. is Rs 11.6171. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Syngene Internation. in Ticker for free. Also, one can get the intrinsic value of Syngene Internation. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Syngene Internation. FAQs

Q1. What is Syngene Internation. share price today?
Ans: The current share price of Syngene Internation. is Rs 649.5.

Q2. What is the market capitalisation of Syngene Internation.?
Ans: Syngene Internation. has a market capitalisation of Rs 26170.915329 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Syngene Internation.?
Ans: The PE ratio of Syngene Internation. is 55.9089617890868 and the P/B ratio of Syngene Internation. is 5.58546317636132, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Syngene Internation. share?
Ans: The 52-week high share price of Syngene Internation. is Rs 960.6, and the 52-week low share price of Syngene Internation. is Rs 599.55.

Q5. Does Syngene Internation. pay dividends?
Ans: Currently, Syngene Internation. pays dividends. Dividend yield of Syngene Internation. is around 0.1924%.

Q6. What are the face value and book value of Syngene Internation. shares?
Ans: The face value of Syngene Internation. shares is Rs 10, while the book value per share of Syngene Internation. is around Rs 116.284. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Syngene Internation.?
Ans: Syngene Internation. has a total debt of Rs 102.5 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Syngene Internation.?
Ans: The ROE of Syngene Internation. is 10.6543% and ROCE of Syngene Internation. is 14.3874%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Syngene Internation. a good buy for the long term?
Ans: The Syngene Internation. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Syngene Internation. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Syngene Internation. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Syngene Internation.’s financials?
Ans: You can review Syngene Internation.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Syngene Internation.
X